Without a growing base of revenue, it's hard to craft a compelling ... PEP), and Moderna (NASDAQ: MRNA). Candy company Hershey is trading near its 52-week low. Moderna (MRNA) stock surged 7% ...

Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...

H.C. Wainwright reaffirmed a Buy rating on Cartesian Therapeutics shares, maintaining the $45.00 price target, representing a ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

where ligands conjugated on the surface of nanoparticles could drive tissue tropisms of mRNA therapeutics. Building a base When asked about the progress Liberate has made on this pathway ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

Everything to Know about Macro and Markets Stocks clocked in their second consecutive weekly gain and the best start to a ...

ASX 200 Futures are indicating a flat open to the market is on the cards today, with a small 0.02% dip in trading likely to open the day on a slightly down note. The US Federal Reserve kept interest ...

Right now, we actually have no plans to move forward; it’s ready to go if we decide,” company spokeswoman said.

RNA is generally single-stranded, as DNA is transcribed by RNA polymerases into mRNA (messenger RNA), which ... pairing between nucleotide bases. Telomerase assembles on a multi-domain RNA ...

Researchers at Tel Aviv University have achieved a breakthrough in drug delivery: they have successfully transported lipid ...